Common Stock, Shares, Issued of Arch Therapeutics, Inc. from 30 Sep 2011 to 30 Jun 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Arch Therapeutics, Inc. quarterly Common Stock, Shares, Issued in shares history and change rate from 30 Sep 2011 to 30 Jun 2024.
  • Arch Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending 30 Jun 2024 was 4,444,364, a 246% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Arch Therapeutics, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 4,444,364 +3,159,151 +246% 30 Jun 2024 10-Q 19 Aug 2024 2024 Q3
Q1 2024 4,444,364 +3,169,759 +249% 31 Mar 2024 10-Q 09 May 2024 2024 Q2
Q4 2023 4,742,364 +3,492,682 +279% 31 Dec 2023 10-Q 20 Feb 2024 2024 Q1
Q3 2023 4,689,446 +3,436,712 +274% 30 Sep 2023 10-Q 19 Aug 2024 2024 Q3
Q2 2023 1,285,213 -235,884,557 -99% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q3
Q1 2023 1,274,605 -235,895,165 -99% 31 Mar 2023 10-Q 23 May 2023 2023 Q2
Q4 2022 1,249,682 -235,920,088 -99% 31 Dec 2022 10-Q 14 Feb 2023 2023 Q1
Q3 2022 1,252,734 -235,917,036 -99% 30 Sep 2022 10-K 15 Feb 2024 2023 FY
Q2 2022 237,169,770 +450,000 +0.19% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q3
Q1 2022 237,169,770 +450,000 +0.19% 31 Mar 2022 10-Q 13 May 2022 2022 Q2
Q4 2021 237,169,770 +44,075,004 +23% 31 Dec 2021 10-Q 11 Feb 2022 2022 Q1
Q3 2021 237,169,770 +44,125,004 +23% 30 Sep 2021 10-K 28 Dec 2022 2022 FY
Q2 2021 236,719,770 +41,129,550 +21% 30 Jun 2021 10-Q 13 Aug 2021 2021 Q3
Q1 2021 236,719,770 +48,856,823 +26% 31 Mar 2021 10-Q 06 May 2021 2021 Q2
Q4 2020 193,094,766 +5,231,819 +2.8% 31 Dec 2020 10-Q 12 Feb 2021 2021 Q1
Q3 2020 193,044,766 +19,467,533 +11% 30 Sep 2020 10-K 17 Dec 2021 2021 FY
Q2 2020 195,590,220 +22,012,987 +13% 30 Jun 2020 10-Q 23 Jul 2020 2020 Q3
Q1 2020 187,862,947 +22,901,098 +14% 31 Mar 2020 10-Q 05 May 2020 2020 Q2
Q4 2019 187,862,947 +22,901,098 +14% 31 Dec 2019 10-Q 30 Jan 2020 2020 Q1
Q3 2019 173,577,233 +9,180,220 +5.6% 30 Sep 2019 10-K 11 Dec 2020 2020 FY
Q2 2019 173,577,233 +19,525,220 +13% 30 Jun 2019 10-Q 01 Aug 2019 2019 Q3
Q1 2019 164,961,849 +10,909,836 +7.1% 31 Mar 2019 10-Q 14 May 2019 2019 Q2
Q4 2018 164,961,849 +10,909,836 +7.1% 31 Dec 2018 10-Q 01 Feb 2019 2019 Q1
Q3 2018 164,397,013 +10,704,156 +7% 30 Sep 2018 10-K 19 Nov 2019 2019 FY
Q2 2018 154,052,013 +3,282,971 +2.2% 30 Jun 2018 10-Q 02 Aug 2018 2018 Q3
Q1 2018 154,052,013 +3,282,971 +2.2% 31 Mar 2018 10-Q 26 Apr 2018 2018 Q2
Q4 2017 154,052,013 +15,869,938 +11% 31 Dec 2017 10-Q 01 Feb 2018 2018 Q1
Q3 2017 153,692,857 +17,035,782 +12% 30 Sep 2017 10-K 18 Dec 2018 2018 FY
Q2 2017 150,769,042 +17,744,763 +13% 30 Jun 2017 10-Q 27 Jul 2017 2017 Q3
Q1 2017 150,769,042 +40,345,454 +37% 31 Mar 2017 10-Q 02 May 2017 2017 Q2
Q4 2016 138,182,075 +29,010,391 +27% 31 Dec 2016 10-Q 01 Feb 2017 2017 Q1
Q3 2016 136,657,075 +29,064,870 +27% 30 Sep 2016 10-K 15 Nov 2017 2017 FY
Q2 2016 133,024,279 +40,321,425 +43% 30 Jun 2016 10-Q 28 Jul 2016 2016 Q3
Q1 2016 110,423,588 +34,347,101 +45% 31 Mar 2016 10-Q 28 Apr 2016 2016 Q2
Q4 2015 109,171,684 +33,095,197 +44% 31 Dec 2015 10-Q 12 Feb 2016 2016 Q1
Q3 2015 107,592,205 +35,515,718 +49% 30 Sep 2015 10-K 05 Dec 2016 2016 FY
Q2 2015 92,702,854 +20,626,367 +29% 30 Jun 2015 10-Q 07 Aug 2015 2015 Q3
Q1 2015 76,076,487 +4,000,000 +5.6% 31 Mar 2015 10-Q 07 May 2015 2015 Q2
Q4 2014 76,076,487 +15,931,250 +26% 31 Dec 2014 10-Q 09 Feb 2015 2015 Q1
Q3 2014 72,076,487 +11,931,250 +20% 30 Sep 2014 10-K 11 Dec 2015 2015 FY
Q2 2014 72,076,487 +13,431,275 +23% 30 Jun 2014 10-Q 06 Aug 2014 2014 Q3
Q1 2014 72,076,487 +66,046,487 +1095% 31 Mar 2014 10-Q 15 May 2014 2014 Q2
Q4 2013 60,145,237 +54,115,237 +897% 31 Dec 2013 10-Q 14 Feb 2014 2014 Q1
Q3 2013 60,145,237 +54,500,025 +965% 30 Sep 2013 10-K 12 Dec 2014 2014 FY
Q2 2013 58,645,212 +52,615,212 +873% 30 Jun 2013 10-Q 14 Aug 2013 2013 Q3
Q1 2013 6,030,000 31 Mar 2013 10-Q 20 May 2013 2013 Q2
Q4 2012 6,030,000 31 Dec 2012 10-Q 14 Feb 2013 2013 Q1
Q3 2012 5,645,212 +1,645,212 +41% 30 Sep 2012 10-K/A 01 May 2014 2013 FY
Q2 2012 6,030,000 30 Jun 2012 10-Q 14 Aug 2012 2012 Q3
Q3 2011 4,000,000 30 Sep 2011 10-K 31 Dec 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.